Onychomycosis is a fungal infection of the nail, most commonly affecting toenails, and it is far more stubborn than most people expect. The condition is caused primarily by a group of fungi called dermatophytes, with one species in particular dominating worldwide cases. Treatment can take months, recurrence is common, and a surprisingly large number of people who assume they have a fungal nail actually have something else entirely. Understanding why this infection behaves the way it does makes the difference between clearing it for good and chasing it in circles for years.
What Causes It and Why Toenails Are the Usual Target
The overwhelming majority of onychomycosis cases are caused by dermatophytes, fungi that have evolved to feed on keratin, the tough protein that makes up nails, skin, and hair. The single most common culprit is Trichophyton rubrum, followed by T. mentagrophytes. Yeasts such as Candida albicans and molds such as Aspergillus species account for the rest, and they tend to be more common in fingernail infections and in warmer climates.1PubMed Central. Onychomycosis: A Review
Toenails get hit far more often than fingernails for straightforward reasons. They grow slowly, giving fungi more time to establish themselves. They spend most of the day enclosed in warm, damp shoes. And the feet are in regular contact with contaminated surfaces like gym floors, pool decks, and shared showers. Fingernail onychomycosis does occur but is more frequently associated with Candida species, and it tends to affect people whose hands are regularly immersed in water.
Who Is Most at Risk
Age is the strongest predictor. Prevalence rises steeply with each decade of life, reaching roughly 20% or more in people over 60 and potentially exceeding 50% in those over 70.2PubMed. Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management Several things converge as people age: nails grow more slowly, blood flow to the extremities decreases, and the immune response to fungal invaders weakens. Older adults are also more likely to have nail dystrophy (misshapen or thickened nails from years of minor trauma), which creates entry points for fungi.3PubMed. Onychomycosis in the elderly: drug treatment options
Diabetes deserves special attention. The infection is both more common and more consequential in people with diabetes. Poor circulation, nerve damage in the feet, and a less effective immune response all raise the risk. In this population, a fungal nail is not just a cosmetic annoyance. It can lead to secondary bacterial infections, foot ulcers, and in serious cases, amputation.4PubMed Central. Onychomycosis in Diabetics: A Common Infection with Potentially Serious Complications If you have diabetes and notice changes in your toenails, getting it checked is not optional.
Other risk factors include psoriasis (which can damage the nail plate and make it hospitable to fungi), immunosuppression from medications or illness, a family history of fungal infections, and having athlete’s foot, which is essentially the same organism living on the surrounding skin and often serves as the source of nail invasion.
Why It Looks Like Other Things
One of the most common mistakes people make is assuming that any thickened, discolored toenail is a fungal infection. Nail psoriasis, lichen planus, trauma, and simple aging can all produce nails that look remarkably similar. One study on the histopathology of nail psoriasis and onychomycosis noted that their clinical features vary in frequency rather than in nature, meaning the same symptoms show up in both conditions, just in different proportions.5Diagnostic Histopathology. Histopathological differential diagnosis of nail psoriasis and onychomycosis A yellow, crumbly nail could be fungal. It could also be psoriatic. Treating one with medications intended for the other wastes months and money.
This is why laboratory confirmation matters before starting treatment, especially before committing to months of oral antifungal medication. The standard approach involves sending a nail clipping for a combination of microscopy (looking for fungal elements under a microscope) and culture (growing whatever is in the nail to identify it). A meta-analysis comparing diagnostic methods found that nail clipping with a particular tissue stain outperformed both direct microscopy and culture alone in terms of accuracy.6PubMed Central. Meta-analysis of the utility of culture, biopsy, and direct KOH examination for the diagnosis of onychomycosis The practical takeaway: if your doctor clips a piece of nail and sends it to the lab before prescribing anything, that is good practice. If a prescription arrives without any testing, you might want to ask questions.
The Biofilm Problem
Onychomycosis has a well-earned reputation for being difficult to treat, and a big part of the explanation lies in biofilms. The fungi that infect nails do not simply sit on the surface waiting to be killed. They form organized communities encased in a protective matrix of their own making, similar to the biofilms that bacteria form on medical implants. This matrix acts as a physical shield, blocking antifungal drugs from reaching the organisms inside.7PubMed. The role of biofilms in onychomycosis
Biofilms are a major reason why the infection can resist treatment and persist for years. Research has highlighted that these structures need to be disrupted before antifungal drugs can work effectively, which supports the growing consensus that combination approaches, using mechanical debridement (physically removing infected nail material) alongside medication, tend to produce better results than medication alone.8PubMed Central. Antibiofilm Treatment for Onychomycosis and Chronic Fungal Infections This is the biological basis for why your dermatologist might trim and file down the nail before applying a topical treatment or starting you on pills.
Oral Antifungal Medications
For moderate-to-severe toenail onychomycosis, oral antifungal drugs are the mainstay of treatment. The two most commonly prescribed are terbinafine and itraconazole, and the evidence consistently favors terbinafine. In a head-to-head trial of 12 weeks of continuous treatment, about 73% of patients taking terbinafine had negative fungal cultures at 48 weeks, compared with about 46% of those on itraconazole.9PubMed. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day Tolerability was similar between the two drugs, with the vast majority of patients in both groups reporting no significant side effects.
Long-term data reinforce the gap. A five-year follow-up study found that roughly 46% of terbinafine-treated patients remained cured without needing retreatment, compared with just 13% of those who had taken itraconazole. Relapse rates were also significantly lower with terbinafine.10JAMA Dermatology. Long-term Effectiveness of Treatment With Terbinafine vs Itraconazole in Onychomycosis: A 5-Year Blinded Prospective Follow-up Study These numbers matter because treating onychomycosis requires patience. Even after a successful course of medication, you will not see a normal-looking nail for months. Toenails grow about 1 to 2 millimeters per month, so a completely new big toenail can take 12 to 18 months to grow out. The medication kills the fungus; the clock handles the cosmetics.
Both drugs require liver function monitoring because, in rare cases, they can cause liver injury. Terbinafine has fewer drug interactions, which makes it the simpler choice for older adults who are typically on multiple medications. Itraconazole, on the other hand, interacts with a long list of common drugs, including certain statins, blood thinners, and heart medications, so the prescriber has to review everything you are taking.
Topical Treatments and When They Make Sense
Topical antifungals are appealing because they avoid the systemic side effects of pills, but they face a fundamental challenge: the nail plate is a dense barrier of keratin, and getting a drug through it in meaningful concentrations is hard. For mild cases, particularly those involving less than half the nail and not affecting the nail’s growth center (the matrix), topical therapy alone can be reasonable.
Efinaconazole 10% topical solution was a notable addition to the topical lineup. It is a triazole antifungal with activity against dermatophytes, Candida, and non-dermatophyte molds.11PubMed Central. Efinaconazole in the treatment of onychomycosis What sets it apart from older topical options like ciclopirox is its low affinity for keratin. Paradoxically, that is a strength: because the drug does not bind tightly to the nail’s keratin, it passes through the nail plate more readily and reaches the fungus underneath in higher concentrations.12PubMed Central. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment A small practical note: lab testing has shown that nail polish does not appear to block efinaconazole’s penetration, which means patients who want to cover a discolored nail cosmetically during treatment may be able to do so.13PubMed Central. Penetration of 14C-Efinaconazole Topical Solution, 10%, Does Not Appear to be Influenced by Nail Polish
Even with newer topical drugs, complete cure rates for topical monotherapy remain lower than for oral treatment. Most dermatologists reserve topical-only regimens for mild infections or for patients who cannot take oral antifungals due to liver disease, drug interactions, or personal preference.
Laser Therapy
Laser treatment for onychomycosis has generated significant interest, particularly among patients who want to avoid systemic medication. The most commonly studied lasers are the 1064-nm Nd:YAG laser and CO2 laser. A meta-analysis reported an overall mycological cure rate of about 63% for laser treatment, with CO2 lasers showing a higher rate of around 74%, though the confidence intervals were wide.14PubMed Central. Laser treatment for onychomycosis Side effects are generally limited to tolerable pain during the session and occasional minor bleeding.
Where lasers look most promising is in combination with topical antifungal agents. A separate meta-analysis of randomized controlled trials found that adding laser therapy to topical treatment significantly improved complete cure rates, mycological cure rates, and patient satisfaction compared with topical agents alone.15PubMed. Efficacy of laser therapy combined with topical antifungal agents for onychomycosis: a systematic review and meta-analysis of randomised controlled trials The working theory is that the laser helps disrupt the nail structure and biofilm, improving drug penetration. Another systematic review and meta-analysis found that laser therapy demonstrated results comparable to terbinafine with fewer adverse effects, though the quality of evidence across laser studies is still mixed.16PubMed Central. Efficacy of Laser Therapy in Comparison With Other Methods for the Treatment of Onychomycosis: A Systematic Review and Meta-Analysis
The practical downside is cost. Laser sessions are typically not covered by insurance, and you usually need several sessions spaced weeks apart. Out-of-pocket costs add up quickly, and the evidence, while encouraging, is not yet strong enough for most medical guidelines to recommend lasers as a first-line standalone treatment.
Recurrence and Why It Happens So Often
Even after a successful treatment course, onychomycosis has a frustrating tendency to come back. One review noted that recurrence may occur in more than half of patients within a year or more after the infection has been cleared, with the extent of original nail involvement and co-existing diabetes being the strongest predictors of return.17PubMed Central. Onychomycosis: Practical Approaches to Minimize Relapse and Recurrence A three-year follow-up of patients who had been successfully treated with systemic antifungals found a cumulative relapse rate of about 22%, rising steadily from about 8% at one year to over 19% at two years.18Dermatology. Relapses of Onychomycosis after Successful Treatment with Systemic Antifungals: A Three-Year Follow-Up In every case in that study, the relapsing infection was caused by the same species, Trichophyton rubrum, raising the question of whether the fungus was never fully eradicated or whether the patients were reinfected from the same environmental source.
A longer follow-up study found that about 16% of patients experienced a recurrence, and that those who had originally been treated with itraconazole relapsed at significantly higher rates than those treated with terbinafine.19PubMed. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents The distinction between relapse (residual fungus that was never fully cleared growing back) and reinfection (catching a new infection from the environment) is clinically important but often impossible to distinguish in practice. Either way, the lesson is that clearing the nail is only half the battle.
Keeping It From Coming Back
Prevention and recurrence reduction boil down to eliminating the environmental reservoir. The same fungi that infect nails survive well on surfaces and in footwear, so treating the nail without addressing the surroundings is like mopping the floor while the faucet is running. Recommendations from a review on hygiene practices against dermatophytic fungi include several practical steps:20PubMed Central. Hygiene Practices Against Dermatophytic Fungi: A Review of Strategies to Combat Antifungal Resistance
- Laundry: Wash socks, towels, and bed linens in hot water (at least 60°C) for 45 minutes or more. Standard warm cycles do not reliably kill dermatophytes.
- Shoes: Use antifungal sprays or disinfectants on shoes and insoles with adequate contact time. Rotate pairs so they dry out completely between wearings.
- Surfaces: Clean shared or high-contact surfaces such as shower floors, locker room benches, and yoga mats with bleach or hydrogen peroxide-based cleaners.
- Tools: Avoid sharing nail clippers or files, and sterilize your own tools regularly.
- Athlete’s foot: Treat any concurrent tinea pedis aggressively. The skin infection on the foot is the most common launchpad for nail infection.
Salon hygiene is also worth mentioning. Shared foot baths and improperly sterilized instruments in nail salons can transmit dermatophytes, particularly T. rubrum. Research has emphasized the need for high-temperature sterilization of tools as a baseline practice to counter persistent fungal pathogens in aesthetic settings.21International Journal of Economics Finance & Management Science. Microbiological Risks and Infection Transmission Pathways in Nail and Aesthetic Practices If you are getting pedicures during or after treatment, bringing your own instruments is a reasonable precaution.
The Emotional Weight of a “Cosmetic” Problem
Onychomycosis is often dismissed as merely cosmetic, but the people living with it frequently tell a different story. A systematic review of the available literature found that the infection physically and psychologically distresses patients.22PubMed Central. The Impact of Onychomycosis on Quality of Life: A Systematic Review of the Available Literature In one study of affected patients, more than half reported feeling embarrassed by the appearance of their nails, 40% said they actively hid their nails from others, and 28% described having a complex about them. Pain, thickening, and discoloration were the most commonly reported symptoms, and the functional burden was significant: 56% were bothered by the time spent on nail care, while 40% reported discomfort wearing shoes.23PubMed Central. Impact of onychomycosis on the quality of life of patients
These numbers matter because they counter the attitude, sometimes held by insurers and even physicians, that treating fungal nails is elective. For people who avoid swimming, going barefoot, wearing open-toed shoes, or even intimacy because of their nails, the condition is not trivial. It changes daily behavior and erodes self-confidence in ways that a lab report cannot capture.
The Fungal Ecosystem on Your Nails
Recent research using DNA sequencing rather than traditional culture has started to reveal a more complex picture of what lives on and in our nails. Healthy nails are not sterile; they host a diverse community of fungi (a “mycobiome”) that varies substantially from person to person. In one study, healthy control subjects showed large individual variation in their nail fungal communities, with no single dominant genus shared across all samples. In patients with onychomycosis, however, the picture split neatly into two groups: about 40% had nails overwhelmingly dominated by Trichophyton (accounting for 80% or more of the fungal DNA detected), while the remaining 60% had fungal diversity similar to healthy people despite being clinically diagnosed with the infection.24Scientific Reports. Biodiversity of mycobial communities in health and onychomycosis
This raises fascinating questions. In the patients whose nails looked infected but harbored a diverse fungal community without Trichophyton dominance, was the diagnosis incorrect? Was a non-dermatophyte organism responsible? Or does disease sometimes arise from shifts in the ecological balance of the existing fungal community rather than from a single invading pathogen? These questions are still open, but the research suggests that the traditional model, one bad fungus invades one clean nail, may be an oversimplification.
Emerging Treatments on the Horizon
The biggest limitation of current topical treatments is getting enough drug through the nail. The research pipeline is focused on solving that delivery problem using nanotechnology-based approaches: nanoparticles, microemulsions, and polymeric films designed to carry antifungal agents through the keratin barrier more efficiently than a simple solution can.25PubMed Central. Novel Drug Delivery Strategies for the Treatment of Onychomycosis Early-stage research is also exploring new antifungal compounds with better nail penetration profiles and longer disease-free periods after treatment.26PubMed Central. Novel and Investigational Treatments for Onychomycosis
Nano-based delivery systems are especially interesting because they could theoretically turn topical treatment into a realistic first-line option for moderate cases, not just mild ones, reducing the need for systemic drugs and the liver monitoring they require.27PubMed. Novel Therapeutic Approaches Emerging in the Field of Onychomycosis None of these are ready for clinical use yet, but the direction of travel is clear: the field is trying to make effective topical therapy that works as well as swallowing a pill. Given that the biggest barriers to treating onychomycosis are treatment duration, side effects, and recurrence, a topical solution that genuinely penetrates the nail would change the game for millions of people.
Fungal Nail Infections and Cellulitis Risk
A concern that surfaces regularly in clinical settings is whether untreated fungal foot infections, including onychomycosis and the athlete’s foot that often accompanies it, raise the risk of cellulitis, a bacterial skin infection that can become serious. A review of 16 studies on the link between fungal foot infection and lower-limb cellulitis found that most papers suggested a connection, though the quality of evidence was uneven. Only two case-control studies used proper microbiological diagnosis, and those did demonstrate that fungal infection between the toes was a risk factor for developing cellulitis in the same leg.28PubMed Central. Fungal foot infection, cellulitis and diabetes: a review The mechanism makes intuitive sense: cracked, macerated skin between the toes provides an entry point for bacteria. There was not enough data to confirm an additional risk specifically for people with diabetes, despite the theoretical reasons to expect one. Still, the plausible link between untreated foot fungus and bacterial infection is one more reason not to ignore persistent changes in your nails or the skin around them, particularly if you have diabetes or circulation problems.